| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S10067-016-3363-1 |
| P698 | PubMed publication ID | 27470088 |
| P2093 | author name string | Nathawut Sibmooh | |
| Supeenun Unchern | |||
| Nadhaporn Saengpetch | |||
| Thitima Kasemsuk | |||
| P2860 | cites work | Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies | Q24558705 |
| Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study | Q28750315 | ||
| Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee | Q29620150 | ||
| Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study | Q29620671 | ||
| Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases | Q33584105 | ||
| Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment | Q33948133 | ||
| Nonsteroidal anti-inflammatory drug-associated dyspepsia: the scale of the problem | Q34134268 | ||
| Bromelain reduces mild acute knee pain and improves well-being in a dose-dependent fashion in an open study of otherwise healthy adults | Q34177340 | ||
| Using Effect Size-or Why the P Value Is Not Enough | Q34368143 | ||
| Efficacy and tolerability of oral enzyme therapy as compared to diclofenac in active osteoarthrosis of knee joint: an open randomized controlled clinical trial | Q34518095 | ||
| Endogenous production of reactive oxygen species is required for stimulation of human articular chondrocyte matrix metalloproteinase production by fibronectin fragments | Q35842797 | ||
| The measurement of blood and plasma nitrite by chemiluminescence: pitfalls and solutions. | Q36545307 | ||
| Effects of flurbiprofen and tiaprofenic Acid on oxidative stress markers in osteoarthritis: A prospective, randomized, open-label, active- and placebo-controlled trial | Q37661071 | ||
| Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors | Q37988860 | ||
| Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association | Q39513001 | ||
| Reaction of linoleic acid hydroperoxide with thiobarbituric acid | Q39640445 | ||
| Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14. | Q39969916 | ||
| Bacoside A and bromelain relieve dichlorvos induced changes in oxidative responses in mice serum | Q42697139 | ||
| Risk factors for NSAID‐associated upper GI clinical events in a long‐term prospective study of 34 701 arthritis patients | Q42855594 | ||
| Synovial tissue inflammation in early and late osteoarthritis | Q43048512 | ||
| Cyclooxygenase-2 expression in lipopolysaccharide-stimulated human monocytes is modulated by cyclic AMP, prostaglandin E(2), and nonsteroidal anti-inflammatory drugs | Q43510686 | ||
| Placebo-controlled randomized clinical trial on the immunomodulating activities of low- and high-dose bromelain after oral administration - new evidence on the antiinflammatory mode of action of bromelain. | Q43602017 | ||
| Determination of the eicosanoid response to inflammatory stimuli in whole blood and its pharmacological modulation ex vivo | Q44473374 | ||
| Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement | Q46597529 | ||
| The presence of molecular markers of in vivo lipid peroxidation in osteoarthritic cartilage: a pathogenic role in osteoarthritis | Q46689837 | ||
| Production of lipid peroxidation products in osteoarthritic tissues: new evidence linking 4-hydroxynonenal to cartilage degradation | Q46873003 | ||
| Perioperative bromelain reduces pain and swelling and improves quality of life measures after mandibular third molar surgery: a randomized, double-blind, placebo-controlled clinical trial | Q47904417 | ||
| [Drug therapy of activated arthrosis. On the effectiveness of an enzyme mixture versus diclofenac] | Q51000179 | ||
| Bromelain as an adjunctive treatment for moderate-to-severe osteoarthritis of the knee: a randomized placebo-controlled pilot study | Q59569150 | ||
| Determination of alpha-tocopherol in tissues and plasma by high-performance liquid chromatography | Q71784004 | ||
| BROMELAINS THERAPY IN RHEUMATOID ARTHRITIS | Q76861127 | ||
| Improved method for the determination of blood glutathione | Q79579725 | ||
| Synthesis and release of human cartilage matrix proteoglycans are differently regulated by nitric oxide and prostaglandin-E2 | Q80280379 | ||
| P433 | issue | 10 | |
| P921 | main subject | osteoarthritis | Q62736 |
| knee osteoarthritis | Q1777118 | ||
| P304 | page(s) | 2531-2540 | |
| P577 | publication date | 2016-07-28 | |
| P1433 | published in | Clinical Rheumatology | Q15754927 |
| P1476 | title | Improved WOMAC score following 16-week treatment with bromelain for knee osteoarthritis | |
| P478 | volume | 35 |
| Q49922324 | Osteoarthritis year in review 2017: clinical. | cites work | P2860 |
Search more.